The role of magnetic resonance imaging in the diagnosis and management of prostate cancer

James Thompson; Nathan Lawrentschuk; Mark Frydenberg; Leslie Thompson; Phillip D Stricker

doi:10.1111/bju.12381

The role of magnetic resonance imaging in the diagnosis and management of prostate cancer

James Thompson
, Nathan Lawrentschuk
, Mark Frydenberg
, Leslie Thompson
, Phillip D Stricker

Surgery Monash Health

Research output: Contribution to journal › Article › Research › peer-review

147 Citations (Scopus)

Abstract

BACKGROUND: The diagnosis of prostate cancer has long been plagued by the absence of an imaging tool that reliably detects and localises significant tumours. Recent evidence suggests that multi-parametric MRI could improve the accuracy of diagnostic assessment in prostate cancer. This review serves as a background to a recent USANZ position statement. It aims to provide an overview of MRI techniques and to critically review the published literature on the clinical application of MRI in prostate cancer. TECHNICAL ASPECTS: The combination of anatomical (T2-weighted) MRI with at least two of the three functional MRI parameters - which include diffusion-weighted imaging, dynamic contrast-enhanced imaging and spectroscopy - will detect greater than 90 of significant (moderate to high risk) tumours; however MRI is less reliable at detecting tumours that are small (

Original language	English
Pages (from-to)	6 - 20
Number of pages	15
Journal	BJU International
Volume	112
Issue number	Suppl 2
DOIs	https://doi.org/10.1111/bju.12381
Publication status	Published - 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1111/bju.12381

Cite this

@article{ebfbf01ac1a14b678ea5b4519cbfb28e,

title = "The role of magnetic resonance imaging in the diagnosis and management of prostate cancer",

abstract = "BACKGROUND: The diagnosis of prostate cancer has long been plagued by the absence of an imaging tool that reliably detects and localises significant tumours. Recent evidence suggests that multi-parametric MRI could improve the accuracy of diagnostic assessment in prostate cancer. This review serves as a background to a recent USANZ position statement. It aims to provide an overview of MRI techniques and to critically review the published literature on the clinical application of MRI in prostate cancer. TECHNICAL ASPECTS: The combination of anatomical (T2-weighted) MRI with at least two of the three functional MRI parameters - which include diffusion-weighted imaging, dynamic contrast-enhanced imaging and spectroscopy - will detect greater than 90 of significant (moderate to high risk) tumours; however MRI is less reliable at detecting tumours that are small (",

author = "James Thompson and Nathan Lawrentschuk and Mark Frydenberg and Leslie Thompson and Stricker, \{Phillip D\}",

year = "2013",

doi = "10.1111/bju.12381",

language = "English",

volume = "112",

pages = "6 -- 20",

journal = "BJU International",

issn = "1464-4096",

publisher = "Wiley-Blackwell",

number = "Suppl 2",

}

TY - JOUR

T1 - The role of magnetic resonance imaging in the diagnosis and management of prostate cancer

AU - Thompson, James

AU - Lawrentschuk, Nathan

AU - Frydenberg, Mark

AU - Thompson, Leslie

AU - Stricker, Phillip D

PY - 2013

Y1 - 2013

N2 - BACKGROUND: The diagnosis of prostate cancer has long been plagued by the absence of an imaging tool that reliably detects and localises significant tumours. Recent evidence suggests that multi-parametric MRI could improve the accuracy of diagnostic assessment in prostate cancer. This review serves as a background to a recent USANZ position statement. It aims to provide an overview of MRI techniques and to critically review the published literature on the clinical application of MRI in prostate cancer. TECHNICAL ASPECTS: The combination of anatomical (T2-weighted) MRI with at least two of the three functional MRI parameters - which include diffusion-weighted imaging, dynamic contrast-enhanced imaging and spectroscopy - will detect greater than 90 of significant (moderate to high risk) tumours; however MRI is less reliable at detecting tumours that are small (

AB - BACKGROUND: The diagnosis of prostate cancer has long been plagued by the absence of an imaging tool that reliably detects and localises significant tumours. Recent evidence suggests that multi-parametric MRI could improve the accuracy of diagnostic assessment in prostate cancer. This review serves as a background to a recent USANZ position statement. It aims to provide an overview of MRI techniques and to critically review the published literature on the clinical application of MRI in prostate cancer. TECHNICAL ASPECTS: The combination of anatomical (T2-weighted) MRI with at least two of the three functional MRI parameters - which include diffusion-weighted imaging, dynamic contrast-enhanced imaging and spectroscopy - will detect greater than 90 of significant (moderate to high risk) tumours; however MRI is less reliable at detecting tumours that are small (

UR - http://onlinelibrary.wiley.com/doi/10.1111/bju.12381/pdf

U2 - 10.1111/bju.12381

DO - 10.1111/bju.12381

M3 - Article

SN - 1464-4096

VL - 112

SP - 6

EP - 20

JO - BJU International

JF - BJU International

IS - Suppl 2

ER -

The role of magnetic resonance imaging in the diagnosis and management of prostate cancer

Abstract

UN SDGs

Access to Document

Other files and links

Cite this